🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

10697+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Showing 20 of 10697 recruiting trials

RecruitingNCT06899581

Gut Health in Children With Cancer

🏥 Great Ormond Street Hospital for Children NHS Foundation Trust📍 1 site📅 Started Jan 2025View details ↗
EARLY_Phase 1RecruitingNCT06792799

Anti-CD19/BCMA CAR-NK Cells in Patients With B Cell Mediated Autoimmune Disease

🏥 The Children's Hospital of Zhejiang University School of Medicine📍 1 site📅 Started Jan 2025View details ↗
Phase 1, PHASE2RecruitingNCT06710132

Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROCEADE PanTumor)

👨‍⚕️ Medical Responsible, Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany📍 81 sites📅 Started Jan 2025View details ↗
NARecruitingNCT06877936

Determination of Scapulothoracic and Glenohumeral Angles by Imaging in Patients After Shoulder Arthroplasty (SCAP-imag)

🏥 Ramsay Générale de Santé📍 1 site📅 Started Jan 2025View details ↗
Phase 2RecruitingNCT06790082

The Diagnostic Accuracy and Clinical Value of FAPI PET in Pleural Mesothelioma

👨‍⚕️ Helle Zacho, MD, DMSc, Clinical Professor dept. of Nuclear Medicine, Aalborg University Hospital📍 1 site📅 Started Jan 2025View details ↗
Phase 2RecruitingNCT06597734

A Phase 2 Study Evaluating Olutasidenib in Combination With Hypomethylating Agents in Patients With IDH1-mutated Higher-risk Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Advanced Myeloproliferative Neoplasm

👨‍⚕️ Kelly Chien, MD, M.D. Anderson Cancer Center📍 1 site📅 Started Jan 2025View details ↗
Phase 1RecruitingNCT06498973

Tagraxofusp and Azacitidine for Maintenance Treatment in Patients With CD123 Positive AML and MDS Following Donor Hematopoietic Cell Transplant

👨‍⚕️ Hoda Z Pourhassan, MD, City of Hope Medical Center📍 1 site📅 Started Jan 2025View details ↗
Phase 1RecruitingNCT06485947

Study Combining Dinutuximab Beta With Two Chemotherapy Regimens in Neuroblastoma

👨‍⚕️ Holger Lode, MD, PhD, Princess Maxima Center for Pediatric Oncology📍 1 site📅 Started Jan 2025View details ↗
RecruitingNCT06805474

A Prospective Observational Study to Assess the Reliability and Validity of the MLSDT

👨‍⚕️ Samuel Barone, MD, Nanoscope Therapeutics Inc.📍 1 site📅 Started Jan 2025View details ↗
NAEnrolling by InvitationNCT06798493

CSS-SR Validation Study

👨‍⚕️ Alexandra Sideris, PhD, Hospital for Special Surgery, New York📍 1 site📅 Started Jan 2025View details ↗
RecruitingNCT06174428

Validity of Viome's Oral/throat Cancer Test

👨‍⚕️ Cristina Julian, Viome📍 2 sites📅 Started Jan 2025View details ↗
Phase 3RecruitingNCT05140525

Effects of Combination Medical Therapy Followed by BPA on Right Ventricular-PA Coupling and Hemodynamics in CTEPH

👨‍⚕️ Sudarshan Rajagopal, MD, PhD, Duke Health System📍 1 site📅 Started Jan 2025View details ↗
Phase 2RecruitingNCT06747923

SB17170 Phase 2 Trial in IPF Patients

🏥 SPARK Biopharma📍 5 sites📅 Started Jan 2025View details ↗
NARecruitingNCT07044804

Non-Invasive Brain Stimulation to Improve Language in Down Syndrome.

🏥 Floriana Costanzo📍 1 site📅 Started Jan 2025View details ↗
Phase 3RecruitingNCT06717347

A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)

👨‍⚕️ Medical Director, Merck Sharp & Dohme LLC📍 248 sites📅 Started Jan 2025View details ↗
NARecruitingNCT06804122

Exercise-based Rehabilitation in Patients With Pulmonary Arterial Hypertension

👨‍⚕️ Jussi A Hernesniemi, MD PhD, Tampere Heart Hospital📍 1 site📅 Started Jan 2025View details ↗
Phase 1, PHASE2RecruitingNCT06709495

Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas

👨‍⚕️ David Shulman, MD, Dana-Farber Cancer Institute📍 3 sites📅 Started Jan 2025View details ↗
NARecruitingNCT06789705

Plasma Oxytocin Changes in Response to Low-dose MDMA vs. Placebo in Patients With Arginine Vasopressin Deficiency and Healthy Controls

👨‍⚕️ Mirjam Christ-Crain, Prof., University Hospital, Basel, Switzerland📍 1 site📅 Started Jan 2025View details ↗
Phase 2RecruitingNCT06524583

Interest of Post-operative Chemotherapy in Patients With Localised Uterine Leiomyosarcoma Suspected of Having a High Risk of Recurrence Based on a Biological Test Performed on the Tumour

👨‍⚕️ Florence DUFFAUD, MD, La TIMONE University Hospital📍 25 sites📅 Started Jan 2025View details ↗
Phase 2, PHASE3RecruitingNCT06767683

A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia

👨‍⚕️ Medical Director, Alkermes, Inc.📍 46 sites📅 Started Jan 2025View details ↗
← PreviousPage 158 of 535Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →